Neil Barnes

13.8k total citations · 4 hit papers
180 papers, 9.4k citations indexed

About

Neil Barnes is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Neil Barnes has authored 180 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Pulmonary and Respiratory Medicine, 131 papers in Physiology and 14 papers in Immunology and Allergy. Recurrent topics in Neil Barnes's work include Asthma and respiratory diseases (131 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (78 papers) and Inhalation and Respiratory Drug Delivery (51 papers). Neil Barnes is often cited by papers focused on Asthma and respiratory diseases (131 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (78 papers) and Inhalation and Respiratory Drug Delivery (51 papers). Neil Barnes collaborates with scholars based in United Kingdom, United States and Netherlands. Neil Barnes's co-authors include Ian Pavord, Tareq W. Ansari, A. B. Kay, T O'Shaughnessy, Steven Pascoe, Nicholas Locantore, Patrick Flood-Page, John Costello, Sally Lettis and P K Jeffery and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Neil Barnes

173 papers receiving 9.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

2003 645 citations Patrick Flood-Page, Andrew Menzies‐Gow et al. Journal of Clinical Investigation profile →
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma

2007 550 citations Patrick Flood-Page, Douglas S. Robinson et al. American Journal of Respiratory and Critical Care Medicine profile →
Inflammation in Bronchial Biopsies of Subjects With Chronic Bronchitis: Inverse Relationship of CD8+ T Lymphocytes With FEV1

1997 514 citations T O'Shaughnessy, Tareq W. Ansari et al. American Journal of Respiratory and Critical Care Medicine profile →
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

2015 504 citations Neil Barnes, Ian Pavord et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Neil Barnes	6.8k	6.8k	1.3k	903	857	180	9.4k
Emílio Pizzichini	7.7k 1.1×	8.9k 1.3×	1.3k 1.0×	1.6k 1.7×	854 1.0×	129	10.7k
Richard Leigh	3.5k 0.5×	4.6k 0.7×	1.6k 1.2×	1.1k 1.2×	581 0.7×	140	7.5k
Elisabeth H. Bel	8.2k 1.2×	9.9k 1.5×	1.6k 1.2×	1.9k 2.1×	738 0.9×	162	12.3k
Alfredo Chetta	4.9k 0.7×	4.0k 0.6×	858 0.7×	787 0.9×	340 0.4×	210	7.5k
Roland Buhl	5.6k 0.8×	5.0k 0.7×	1000 0.8×	1.5k 1.7×	404 0.5×	224	9.6k
Piero Maestrelli	5.8k 0.8×	5.0k 0.7×	1.5k 1.1×	707 0.8×	1.2k 1.4×	160	10.0k
Renaud Louis	4.3k 0.6×	4.1k 0.6×	1.7k 1.3×	924 1.0×	402 0.5×	336	8.2k
Catherine Lemière	4.0k 0.6×	5.3k 0.8×	1.7k 1.3×	988 1.1×	384 0.4×	205	9.0k
Marina Saetta	9.2k 1.4×	6.7k 1.0×	1.9k 1.5×	523 0.6×	1.6k 1.9×	230	13.2k
Teal S. Hallstrand	4.8k 0.7×	3.7k 0.5×	722 0.6×	510 0.6×	325 0.4×	90	7.6k

Countries citing papers authored by Neil Barnes

Since Specialization

Citations

This map shows the geographic impact of Neil Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Barnes more than expected).

Fields of papers citing papers by Neil Barnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Barnes. The network helps show where Neil Barnes may publish in the future.

Co-authorship network of co-authors of Neil Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Barnes. A scholar is included among the top collaborators of Neil Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Barnes. Neil Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Tan, Wan C., Jean Bourbeau, Gilbert Nadeau, et al.. (2020). High eosinophil counts predict decline in FEV₁: results from the CanCOLD study. European Respiratory Journal. 57(5). 2000838–2000838. 41 indexed citations

2.

Bousquet, Jean, Neil Barnes, M.R.J. Gibbs, et al.. (2018). INHALED SALMETEROL/FLUTICASONE PROPIONATE IS MORE EFFECTIVE THAN FLUTICASONE PROPIONATE ALONE AT ACHIEVING WELL-CONTROLLED ASTHMA IN ASIAN PATIENTS: A POST HOC ANALYSIS OF THE GOAL STUDY. Respirology. 20. 13. 1 indexed citations

3.

Contoli, Marco, Maria Rita Rossi, Antonio Spanevello, et al.. (2017). Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. European Respiratory Journal. 50(4). 1700451–1700451. 115 indexed citations

4.

Prazma, Charlene M., Elisabeth H. Bel, Neil Barnes, et al.. (2016). Steroid Sparing Response with Mepolizumab: Durability of Steroid Reduction in Severe Asthma. Journal of Allergy and Clinical Immunology. 137(2). AB16–AB16. 4 indexed citations

5.

Chapman, Sarah, et al.. (2015). Changing adherence-related beliefs about ICS maintenance treatment for asthma: feasibility study of an intervention delivered by asthma nurse specialists. BMJ Open. 5(6). e007354–e007354. 20 indexed citations

6.

Barnes, Neil, Shu Hashimoto, Takahide Nagase, et al.. (2013). QVA149 provides superior peak lung function in patients with COPD. European Respiratory Journal. 42(Suppl 57). P3634–P3634. 2 indexed citations

7.

Serra, É., Michael Spaeth, Benoît Arnould, et al.. (2011). Development of the Fibromyalgia Burden Assessment: measuring the multifaceted burden of fibromyalgia.. PubMed. 28(6 Suppl 63). S87–93. 5 indexed citations

8.

Haughney, John, David Price, Neil Barnes, et al.. (2010). Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs. Respiratory Medicine CME. 3(3). 125–131. 36 indexed citations

9.

Gamble, Elizabeth, Diana C. Grootendorst, Keith Hattotuwa, et al.. (2007). Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis. European Respiratory Journal. 30(3). 467–471. 121 indexed citations

10.

Flood-Page, Patrick, Andrew Menzies‐Gow, Simon Phipps, et al.. (2003). Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. Journal of Clinical Investigation. 112(7). 1029–1036. 59 indexed citations

11.

Flood-Page, Patrick, Andrew Menzies‐Gow, Simon Phipps, et al.. (2003). Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. Journal of Clinical Investigation. 112(7). 1029–1036. 645 indexed citations breakdown →

12.

Sun, Ying, Lubna Khan, Q. Meng, Neil Barnes, & A B Kay. (2003). Cyclosporin A, apoptosis of BAL T‐cells and expression of Bcl‐2 inasthmatics. European Respiratory Journal. 22(2). 207–212. 19 indexed citations

13.

Serracino‐Inglott, Ferdinand, et al.. (2003). Renal artery aneurysm presenting with microscopic hematuria. Journal of Vascular Surgery. 38(3). 620–620. 2 indexed citations

14.

Chung, Fu‐Tsai, Neil Barnes, Mary Beth Allen, et al.. (2002). Assessing the burden of respiratory disease in the UK. Respiratory Medicine. 96(12). 963–975. 46 indexed citations

15.

Hattotuwa, Keith, et al.. (2002). The Effects of Inhaled Fluticasone on Airway Inflammation in Chronic Obstructive Pulmonary Disease: A Double-Blind, Placebo-controlled Biopsy Study. American Journal of Respiratory and Critical Care Medicine. 165(12). 1592–1596. 213 indexed citations

16.

Zhu, Jie, Swati Majumdar, Elizabeth Gamble, et al.. (2001). Exacerbations of Bronchitis. American Journal of Respiratory and Critical Care Medicine. 164(1). 109–116. 144 indexed citations

17.

O'Shaughnessy, T, Tareq W. Ansari, Neil Barnes, & P K Jeffery. (1997). Inflammation in Bronchial Biopsies of Subjects With Chronic Bronchitis: Inverse Relationship of CD8+ T Lymphocytes With FEV1. American Journal of Respiratory and Critical Care Medicine. 155(3). 852–857. 514 indexed citations breakdown →

18.

Löck, Steffen, A. B. Kay, & Neil Barnes. (1996). Double-Blind, Placebo-Controlled Study of Cyclosporin A as a Corticosteroid-Sparing Agent in Corticosteroid-Dependent Asthma. American Journal of Respiratory and Critical Care Medicine. 153(2). 509–514. 140 indexed citations

19.

Kuitert, L.M., Robert Angus, Neil Barnes, et al.. (1995). Effect of a Novel Potent Platelet-Activating Factor Antagonist, Modipafant, in Clinical Asthma. American Journal of Respiratory and Critical Care Medicine. 151(5). 1331–1335. 49 indexed citations

20.

Barnes, Neil, et al.. (1988). Studies of leukotriene antagonists and synthesis inhibitors in man.. PubMed. 263. 393–403. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact